Surviving Stage 3 Invasive Lobular Carcinoma: A Personal Journey

Stage 3 invasive lobular carcinoma (ILC) is a challenging condition, but with the right approach, patients can improve their chances of survival and quality of life. This article shares insights from a survivor, personal tips, and scientific recommendations for managing this form of breast cancer.

Understanding Breast Cancer: ER Description

Breast cancer can be classified based on the presence or absence of specific receptors. ER (estrogen receptor)-positive cancers like ILC often have a relatively favorable prognosis when treated with standard care. However, HER2-negative cancers, which ILC is, pose additional challenges due to their resistance to certain treatments, such as Herceptin (trastuzumab).

Personal Reflections on Survival

For some, the belief that one must wait for the shower to stop running before drying off is a metaphor for understanding the root causes of cancer and addressing the underlying issues. While traditional treatments like chemotherapy are widely used, they may not always be sufficient, especially in cases of HER2-negative, ER-positive ILC.

Some patients choose to explore alternative and integrative methods, such as IV vitamin infusions and far-infrared saunas, which can complement conventional therapy. Emotional well-being and mental health play crucial roles in the recovery process, as I have personally experienced.

Scientific Recommendations for ER Positive, HER2 Negative ILC

Based on clinical guidelines, patients with ER positive, HER2 negative ILC typically have a 5-year survival rate exceeding 85%. However, there is always a risk of recurrence, particularly in cases where chemotherapy has partial success.

Following surgical removal, patients often undergo additional treatments such as radiation therapy and hormone therapy, which help reduce the risk of recurrence. For younger women, ovarian suppression is also an option, while hormone therapy continues for a decade or more.

Role of Lifestyle in Long-Term Survival and Quality of Life

Lifestyle choices significantly impact the recurrence risk of ER positive breast cancers, including ILC. Maintaining an optimal weight, engaging in regular exercise, and managing stress are crucial.

Exercise, including muscle-building exercises, reduces inflammation and enhances immune function. Meal planning with specific timing and food choices can also help manage insulin levels, which are linked to cell growth and proliferation. Consulting with health professionals for second opinions is always advisable, especially through resources like Harvard's Dana Farber Cancer Institute or the Cleveland Clinic.

Conclusion

While ER positive, HER2 negative invasive lobular carcinoma can be a formidable challenge, a proactive and holistic approach can improve outcomes. By focusing on both conventional and alternative therapies, along with lifestyle modifications, patients can achieve a higher quality of life and better control over their health.

Keywords

invasive lobular carcinoma HER2 negative breast cancer alternative treatments